Biotech · Private company · Rockville, MD, US
Hbvtech
Track this companyFree. Adds Hbvtech to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- A development strategy to obtain IND approval of HBVZ10, a new HBV cure therapy candidateFiscal year 2025 · $258.8KNIH RePORTER 1R34AI194337-01 · fetched Nov 12, 2026
- Evaluating HBVZ10-Based Therapies for cccDNA Clearance: Virological Foundation and Synergistic CombinationsFiscal year 2025 · $606.2KNIH RePORTER 75N93025C00023-0-9999-1 · fetched Nov 12, 2026